Pharmacosmos A/S
🇩🇰Denmark
Iron Isomaltoside 1000 (Monofer®) in Non-Dialysis Dependent Chronic Kidney Disease and With Renal-Related Anaemia
Phase 3
Completed
- Conditions
- Iron Deficiency AnemiaChronic Kidney Disease
- Interventions
- First Posted Date
- 2010-04-13
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 351
- Registration Number
- NCT01102413
- Locations
- 🇩🇰
Pharmacosmos, Holbaek, Denmark
Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia
- First Posted Date
- 2009-11-20
- Last Posted Date
- 2012-11-27
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 350
- Registration Number
- NCT01017614
- Locations
- 🇬🇧
Research Site, London, United Kingdom
A Study of Iron Oligosaccharide in CHF Patients
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2008-10-08
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 20
- Registration Number
- NCT00537186
- Locations
- 🇩🇰
Roskilde University Hospital, Medicinsk afdeling, Roskilde, Denmark
A Study of Iron Oligosaccharide in Chronic Kidney Disease Patients
Phase 3
Completed
- Conditions
- Chronic Kidney DiseaseAnemia, Iron-Deficiency
- Interventions
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2008-10-08
- Lead Sponsor
- Pharmacosmos A/S
- Target Recruit Count
- 182
- Registration Number
- NCT00536666
- Locations
- 🇩🇰
Rigshospitalet, Nefrologisk afdeling P, Copenhagen, Denmark
© Copyright 2025. All Rights Reserved by MedPath